{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T07:45:46Z","timestamp":1776671146678,"version":"3.51.2"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Div"],"DOI":"10.1186\/s13008-026-00180-6","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T15:36:31Z","timestamp":1773243391000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The roles and pathways of Hsa_circ_0000285 in cancer: a potential target for cancer therapy"],"prefix":"10.1186","volume":"21","author":[{"given":"Yan","family":"Lv","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qun-Xian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang-Yu","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiao-Ya","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,11]]},"reference":[{"issue":"1","key":"180_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-022-02466-3","volume":"41","author":"Q Ma","year":"2022","unstructured":"Ma Q, Yang F, Huang B, Pan X, Li W, Yu T, et al. CircARID1A binds to IGF2BP3 in gastric cancer and promotes cancer proliferation by forming a circARID1A-IGF2BP3-SLC7A5 RNA-protein ternary complex. J Exp Clin Cancer Res. 2022;41(1):251. https:\/\/doi.org\/10.1186\/s13046-022-02466-3.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"180_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-024-11984-6","volume":"24","author":"LX Yuan","year":"2024","unstructured":"Yuan LX, Luo M, Liu RY, Wang HX, Ju LL, Wang F, et al. Hsa_circ_0005397 promotes hepatocellular carcinoma progression through EIF4A3. BMC Cancer. 2024;24(1):239. https:\/\/doi.org\/10.1186\/s12885-024-11984-6.","journal-title":"BMC Cancer"},{"key":"180_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2022.153914","volume":"234","author":"J Yang","year":"2022","unstructured":"Yang J, Qi F, Tan B, Dai G, Chen R, Wan W, et al. CircSPECC1 promotes bladder cancer progression via regulating miR-136-5p\/GNAS axis. Pathol Res Pract. 2022;234:153914. https:\/\/doi.org\/10.1016\/j.prp.2022.153914.","journal-title":"Pathol Res Pract"},{"issue":"3","key":"180_CR4","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s10528-022-10287-4","volume":"61","author":"Z Mao","year":"2023","unstructured":"Mao Z, Lin D, Xu J. Hsa_circ_0001535 regulates colorectal cancer progression via the miR-433-3p\/RBPJ axis. Biochem Genet. 2023;61(3):861\u201378. https:\/\/doi.org\/10.1007\/s10528-022-10287-4.","journal-title":"Biochem Genet"},{"issue":"1","key":"180_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s11658-022-00364-2","volume":"27","author":"H Ma","year":"2022","unstructured":"Ma H, Qu S, Zhai Y, Yang X. Circ_0025033 promotes ovarian cancer development via regulating the hsa_miR-370-3p\/SLC1A5 axis. Cell Mol Biol Lett. 2022;27(1):94. https:\/\/doi.org\/10.1186\/s11658-022-00364-2.","journal-title":"Cell Mol Biol Lett"},{"issue":"9\u201310","key":"180_CR6","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s10495-022-01743-y","volume":"27","author":"P Huang","year":"2022","unstructured":"Huang P, Li M, Tang Q, Jiang K, Luo Y. Circ_0000523 regulates miR-1184\/COL1A1\/PI3K\/Akt pathway to promote nasopharyngeal carcinoma progression. Apoptosis. 2022;27(9\u201310):751\u201361. https:\/\/doi.org\/10.1007\/s10495-022-01743-y.","journal-title":"Apoptosis"},{"issue":"6","key":"180_CR7","doi-asserted-by":"publisher","first-page":"437","DOI":"10.2174\/0109298665297110240611115010","volume":"31","author":"H Ge","year":"2024","unstructured":"Ge H, Yan Y, Wang H, Bian J, Deng Z, Su X, et al. Circular RNA hsa_circ_0005939 regulates UHRF1BP1L expression by targeting miR-4693-3p to promote colorectal cancer progression. Protein Pept Lett. 2024;31(6):437\u201346. https:\/\/doi.org\/10.2174\/0109298665297110240611115010.","journal-title":"Protein Pept Lett"},{"issue":"1","key":"180_CR8","doi-asserted-by":"publisher","first-page":"61","DOI":"10.2174\/0109298665268943231103114654","volume":"31","author":"Z Lv","year":"2024","unstructured":"Lv Z, Shi Y, Wu H, Cao K, Liu X, Wang C. Novel circular RNA CircUBAP2 drives tumor progression by regulating the miR-143\/TFAP2B axis in prostate cancer. Protein Pept Lett. 2024;31(1):61\u201373. https:\/\/doi.org\/10.2174\/0109298665268943231103114654.","journal-title":"Protein Pept Lett"},{"key":"180_CR9","doi-asserted-by":"publisher","DOI":"10.2174\/1874467216666230217151946","volume":"17","author":"Q Zeng","year":"2024","unstructured":"Zeng Q, Feng K, Yu Y, Lv Y. Hsa_Circ_0000021 sponges miR-3940-3p\/KPNA2 expression to promote cervical cancer progression. Curr Mol Pharmacol. 2024;17:e170223213775. https:\/\/doi.org\/10.2174\/1874467216666230217151946.","journal-title":"Curr Mol Pharmacol"},{"issue":"3","key":"180_CR10","doi-asserted-by":"publisher","first-page":"317","DOI":"10.2174\/0115665232301878240627051455","volume":"25","author":"J Qian","year":"2025","unstructured":"Qian J, Jiang B, Qin Z, Tan Y. Knockdown of hsa_circ_0102231 impedes the progression of liver cancer through the miR-873-SOX4 axis. Curr Gene Ther. 2025;25(3):317\u201326. https:\/\/doi.org\/10.2174\/0115665232301878240627051455.","journal-title":"Curr Gene Ther"},{"key":"180_CR11","doi-asserted-by":"publisher","DOI":"10.1177\/09603271221115400","volume":"41","author":"J Huang","year":"2022","unstructured":"Huang J, Zhou H, Diao Y, Yang Z. Hsa_circ_0000285 knockdown inhibits the progression of hepatocellular carcinoma by sponging miR-582-3p to regulate CCNB2 expression. Hum Exp Toxicol. 2022;41:9603271221115400. https:\/\/doi.org\/10.1177\/09603271221115400.","journal-title":"Hum Exp Toxicol"},{"issue":"6","key":"180_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.24475","volume":"36","author":"X Wang","year":"2022","unstructured":"Wang X, Tan M, Huang H, Zou Y, Wang M. Hsa_circ_0000285 contributes to gastric cancer progression by upregulating FN1 through the inhibition of miR-1278. J Clin Lab Anal. 2022;36(6):e24475. https:\/\/doi.org\/10.1002\/jcla.24475.","journal-title":"J Clin Lab Anal"},{"issue":"2","key":"180_CR13","doi-asserted-by":"publisher","first-page":"197","DOI":"10.4149\/neo_2018_180318N185","volume":"66","author":"BJ Chi","year":"2019","unstructured":"Chi BJ, Zhao DM, Liu L, Yin XZ, Wang FF, Bi S, Gui SL, Zhou SB, Qin WB, Wu DM, Wang SQ. Downregulation of hsa_circ_0000285 serves as a prognostic biomarker for bladder cancer and is involved in cisplatin resistance. Neoplasma. 2019;66(2):197\u2013202. https:\/\/doi.org\/10.4149\/neo_2018_180318N185.","journal-title":"Neoplasma"},{"issue":"5","key":"180_CR14","doi-asserted-by":"publisher","first-page":"6495","DOI":"10.3892\/ol.2018.9471","volume":"16","author":"M Shuai","year":"2018","unstructured":"Shuai M, Hong J, Huang D, Zhang X, Tian Y. Upregulation of circRNA_0000285 serves as a prognostic biomarker for nasopharyngeal carcinoma and is involved in radiosensitivity. Oncol Lett. 2018;16(5):6495\u2013501. https:\/\/doi.org\/10.3892\/ol.2018.9471.","journal-title":"Oncol Lett"},{"key":"180_CR15","doi-asserted-by":"publisher","DOI":"10.1177\/09603271221141689","volume":"42","author":"Q Zeng","year":"2023","unstructured":"Zeng Q, Ji X, Li X, Tian Y. Circ_0000285 regulates nasopharyngeal carcinoma progression through miR-1278\/FNDC3B axis. Hum Exp Toxicol. 2023;42:9603271221141689. https:\/\/doi.org\/10.1177\/09603271221141689.","journal-title":"Hum Exp Toxicol"},{"key":"180_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-020-01557-5","volume":"20","author":"Z Long","year":"2020","unstructured":"Long Z, Gong F, Li Y, Fan Z, Li J. Circ_0000285 regulates proliferation, migration, invasion and apoptosis of osteosarcoma by miR-409-3p\/IGFBP3 axis. Cancer Cell Int. 2020;20:481. https:\/\/doi.org\/10.1186\/s12935-020-01557-5.","journal-title":"Cancer Cell Int"},{"issue":"5","key":"180_CR17","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/s41434-019-0112-5","volume":"27","author":"Z Zhang","year":"2020","unstructured":"Zhang Z, Pu F, Wang B, Wu Q, Liu J, Shao Z. Hsa_circ_0000285 functions as a competitive endogenous RNA to promote osteosarcoma progression by sponging hsa-miRNA-599. Gene Ther. 2020;27(5):186\u201395. https:\/\/doi.org\/10.1038\/s41434-019-0112-5.","journal-title":"Gene Ther"},{"issue":"7","key":"180_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.24421","volume":"36","author":"B Zhang","year":"2022","unstructured":"Zhang B, Li Q, Song Z, Ren L, Gu Y, Feng C, et al. Hsa_circ_0000285 facilitates thyroid cancer progression by regulating miR-127-5p\/CDH2. J Clin Lab Anal. 2022;36(7):e24421. https:\/\/doi.org\/10.1002\/jcla.24421.","journal-title":"J Clin Lab Anal"},{"issue":"3","key":"180_CR19","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2021.12934","volume":"22","author":"R Gao","year":"2021","unstructured":"Gao R, Ye H, Gao Q, Wang N, Zhou Y, Duan H. Inhibition of circular RNA_0000285 prevents cell proliferation and induces apoptosis in thyroid cancer by sponging microRNA-654-3p. Oncol Lett. 2021;22(3):673. https:\/\/doi.org\/10.3892\/ol.2021.12934.","journal-title":"Oncol Lett"},{"issue":"3","key":"180_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.24207","volume":"36","author":"F Liu","year":"2022","unstructured":"Liu F, Duan C, Han Y. Circular RNA hsa_circ_0000285 regulates the microRNA-599\/G-protein subunit gamma 12 (miR-599\/GNG12) axis to promote glioma progression. J Clin Lab Anal. 2022;36(3):e24207. https:\/\/doi.org\/10.1002\/jcla.24207.","journal-title":"J Clin Lab Anal"},{"issue":"3","key":"180_CR21","doi-asserted-by":"publisher","first-page":"4757","DOI":"10.1080\/21655979.2022.2031673","volume":"13","author":"T Deng","year":"2022","unstructured":"Deng T, Liu Y, Yang Y, Yuan L, Liu F, Wang X, et al. Regulation of microRNA miR-197-3p\/CDC28 protein kinase regulatory subunit 1B (CKS1B) axis by circular RNA hsa_circ_0000285 promotes glioma progression. Bioengineered. 2022;13(3):4757\u201372. https:\/\/doi.org\/10.1080\/21655979.2022.2031673.","journal-title":"Bioengineered"},{"issue":"20","key":"180_CR22","doi-asserted-by":"publisher","first-page":"8771","DOI":"10.26355\/eurrev_201910_19271","volume":"23","author":"RX Chen","year":"2019","unstructured":"Chen RX, Liu HL, Yang LL, Kang FH, Xin LP, Huang LR, Guo QF, Wang YL. Circular RNA circRNA_0000285 promotes cervical cancer development by regulating FUS. Eur Rev Med Pharmacol Sci. 2019;23(20):8771\u20138. https:\/\/doi.org\/10.26355\/eurrev_201910_19271.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"180_CR23","doi-asserted-by":"publisher","first-page":"8663","DOI":"10.2147\/CMAR.S253174","volume":"12","author":"W Zhang","year":"2020","unstructured":"Zhang W, Zhang S. Downregulation of circRNA_0000285 suppresses cervical cancer development by regulating miR197-3p-ELK1 axis. Cancer Manag Res. 2020;12:8663\u201374. https:\/\/doi.org\/10.2147\/CMAR.S253174.","journal-title":"Cancer Manag Res"},{"issue":"3","key":"180_CR24","doi-asserted-by":"publisher","first-page":"5251","DOI":"10.1080\/21655979.2022.2037870","volume":"13","author":"S Zhang","year":"2022","unstructured":"Zhang S, Xu Y, Zheng Q. CircRNA_0000285 knockdown suppresses viability and promotes apoptosis of cervical cancer cells by sponging microRNA-654-3p. Bioengineered. 2022;13(3):5251\u201361. https:\/\/doi.org\/10.1080\/21655979.2022.2037870.","journal-title":"Bioengineered"},{"issue":"1","key":"180_CR25","doi-asserted-by":"publisher","DOI":"10.1080\/01443615.2023.2196344","volume":"43","author":"H Chen","year":"2023","unstructured":"Chen H, Tian X, Luan Y, Lu H. Highly expressed circ_0000285 from serum and cervical exfoliated cells as a novel biomarker for the diagnosis of early stage-cervical cancer. J Obstet Gynaecol. 2023;43(1):2196344. https:\/\/doi.org\/10.1080\/01443615.2023.2196344.","journal-title":"J Obstet Gynaecol"},{"issue":"1","key":"180_CR26","doi-asserted-by":"publisher","DOI":"10.1515\/med-2023-0726","volume":"18","author":"J Du","year":"2023","unstructured":"Du J, Zhuo Y, Sun X, Nie M, Yang J, Luo X, et al. Hsa_circ_0000285 sponging miR-582-3p promotes neuroblastoma progression by regulating the Wnt\/\u03b2-catenin signaling pathway. Open Med. 2023;18(1):20230726. https:\/\/doi.org\/10.1515\/med-2023-0726.","journal-title":"Open Med"}],"container-title":["Cell Division"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13008-026-00180-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13008-026-00180-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13008-026-00180-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T06:53:36Z","timestamp":1776668016000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13008-026-00180-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,11]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["180"],"URL":"https:\/\/doi.org\/10.1186\/s13008-026-00180-6","relation":{},"ISSN":["1747-1028"],"issn-type":[{"value":"1747-1028","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,11]]},"assertion":[{"value":"27 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7"}}